This report provides exclusive insights into the COVID-19 impact on the Insulin Delivery System Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Insulin Delivery System Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Insulin Delivery System Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on insulin delivery system market provides in-depth
analysis of segments and sub-segments in the global as well as regional insulin
delivery system market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional insulin delivery
system market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of global
insulin delivery system market. According to the report, the insulin delivery
system market was worth USD 9724.4 million in 2016 and it is expected to reach
USD 14537 million by 2024. The global insulin delivery system market is
projected to grow at a CAGR of 5.02% over the forecast period of 2018-2024.
The patient is moving from hospitals
to specialty clinics, users prefer syringes and insulin pens because of their
low cost, refining policies for compensation, and availability, affordability
of devices, are some of the key factor driving the growth of global insulin
delivery system market moreover, needle nervousness in patients affect the
growth of the pen needles and syringes market, problems related to the reuse
of pen needles and infusion sets are the key factors restraining the growth of
this market. Growing research and development, increasing expenditure in
emerging economies on diabetes-related health are likely to bring more
opportunities in this market.
Geographically, the market is
divided into the Americas, Europe, APAC and RoW. The U.S is a key country that
is driving the North America insulin delivery system market. The APAC region is
expected to grow at the fastest CAGR over the forecast period. India and China
are known as the diabetes capital of the world. Both countries are among the
top 3 countries with a high number of the diabetic population. Going further,
government initiatives in healthcare policies and rising disposable income are
among the vital factors that would lead to the adoption of the insulin delivery
system market in the Asia-Pacific region.
The report on global insulin
delivery system market covers segments such as product type, and end user. On
the basis of product type, the sub-markets include insulin pens, Insulin jet
injectors, syringes, and insulin pumps. On the basis of end user, the sub-markets
include specialty diabetic clinics, hospitals, and retail Channels.
The report provides profiles of
the companies in the market such as Eli Lilly and Company, Ypsomed Holding AG,
Becton, Dickinson and Company, Novo Nordisk A/S, Tandem Diabetes Care, Inc.,
Medtronic PLC, Sanofi, Animas Corporation (Johnson and Johnson), Insulet
Corporation, and Biocon Limited.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of insulin delivery system market. Moreover, the study highlights
current market trends and provides forecast from 2018-2024. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.